People in the UK have a high level of trust in pharmacies and many are keen on seeing the Pharmacy First initiative expanded, according to the 2024 STADA
Health Report published today (24 June).
The 10th annual health report by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, involved a survey of over 46,000
respondents across 23 countries, including 2,000 participants from the UK.
The UK data showed an overwhelming trust in UK pharmacies, with 94 per cent of those surveyed (more than nine out of 10 Brits) saying they have only ever had
good advice from a pharmacist.
The report also indicated a strong desire for the Pharmacy First scheme to be expanded, with 44 per cent of respondents advocating for an increase in pharmacists'
scope of responsibilities to support doctors.
Amid the rapid rise in semaglutide usage, a study has suggested a potential risk of a rare eye condition associated with the weight loss drug.
Semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is available under the brand name Ozempic (by Novo Nordisk) in a lower-dose form for managing
type 2 diabetes mellitus (T2DM), and as Wegovy (also by Novo Nordisk) in a higher-dose form for weight management in patients with high body mass indexes.
Anecdotal evidence has indicated that semaglutide might be linked to nonarteritic anterior ischemic optic neuropathy (NAION).
To investigate this potential connection, researchers in the United States analysed data over a six-year period from nearly 17,000 neuro-ophthalmology patients at
Massachusetts Eye and Ear Hospital in Boston, Massachusetts, all of whom had no prior history of NAION.
"Raise awareness of pharmacies as places of primary health care provision," advocates the International Pharmaceutical Federation (FIP), emphasising the
need for universal recognition of pharmacists as essential healthcare professionals.
Despite significant advancements in pharmacy practice, many policymakers and members of the public still view pharmacies primarily as commercial enterprises
rather than essential providers of healthcare services.
The FIP is leading a campaign to change this perception, advocating for pharmacies to be recognised as vital components of primary health care.
Primary health care is crucial for achieving "health for all."
In 2018, the Declaration of Astana saw governments recommit to strengthening primary health care to achieve universal health coverage.
FIP, a signatory to this declaration, has since been dedicated to enhancing the role and impact of pharmacies in primary health care.
There is a state of "emergency" across the community pharmacy sector, the National Pharmacy Association (NPA) has warned.
The organisation is holding a day of protest action, called 'One Day to #SaveOurPharmacies', on 20 June to draw attention to the sector's growing crisis.
During the protest, pharmacy teams across the UK are expected to take a range of symbolic actions - such as turning the lights out for a period, asking their
staff to wear black, blacking out windows, using the day to engage with patients, inviting parliamentary candidates and using #saveourpharmacies on social
media - signifying dark times for the beleaguered community pharmacy sector, the NPA said.
The organisation decided to choose 20 June for the protest as it marks the day from which the average pharmacy across the four nations will be "lossmaking
overall."
A snap survey conducted by the National Pharmacy Association (NPA) revealed that over half of community pharmacy teams have felt unsafe in the past week
due to ongoing riots across the country.
The survey, which included responses from approximately 350 community pharmacies, also found that one in three pharmacies had considered closing because of
safety concerns, while 13 per cent of pharmacy teams reported experiencing racist comments during this period.
According to the NPA, over 40 per cent of pharmacists are of South Asian, Black, or other ethnic minority backgrounds, with the majority of independent community
pharmacy owners believed to be of South Asian heritage.
The association reports that businesses had been vandalised during the riots, leading some pharmacies to reduce their opening hours or close entirely, following
advice from the police and local authorities.
Despite a recent decline in disorder over the last few days, police have been advised to remain on high alert over the weekend.
In recent years, the healthcare sector has seen a significant transformation driven by the rapid advancement of technology. From improved patient care to
streamlined administrative processes, technology has become an indispensable part of modern healthcare. As medical facilities worldwide embrace these innovations,
it's essential to understand why the sector leans so heavily on advanced technological solutions. Below are seven key reasons illustrating the crucial role of
technology in healthcare.
Enhanced Radiology Workflows
Advancements in technology have revolutionized radiology workflows, making the process more efficient and accurate. Digital imaging technologies, such as
PACS (Picture Archiving and Communication Systems) and RIS (Radiology Information Systems), allow for the seamless storage, retrieval, and sharing of medical
images. The specialists AbbaDox say that this reduces the time needed to diagnose and treat patients, significantly improving the overall efficiency of radiology
departments. Additionally, AI-powered tools can assist radiologists by highlighting potential areas of concern within images, ensuring that abnormalities are not
overlooked. These improvements contribute to faster, more accurate diagnoses and better patient outcomes.
Ensuring comprehensive healthcare services for the community necessitates collaboration between pharmacies and GP surgeries. However, several pharmacists
have voiced concerns about a lack of cooperation from their local GPs in implementing the Pharmacy First (PF) service.
In a survey conducted by the National Pharmacy Association (NPA) covering 470 pharmacies across England, three-quarters of pharmacists (77 per cent) indicated
that local GP practices are not appropriately referring patients to the new service.
The survey highlighted instances of patients either not being referred or being referred but found ineligible for support through Pharmacy First. Additionally,
one in five NPA members (19 per cent) felt that their local GP practices were not engaging with the initiative at all.
Commenting on the issue, NPA chair Nick Kaye said: "Feedback from across our network suggests that the rollout of Pharmacy First varies considerably from area
to area.
Community Pharmacy England (CPE) is gearing up to conduct a vital Pharmacy Advice Audit, calling on pharmacy owners and their teams to help measure the
increasing reliance on pharmacies within communities.
With years of financial strains impacting the sector, despite the much-needed £645 million recovery plan funding, the sector finds itself on the edge.
The launch of Pharmacy First sparked a notable surge in people seeking advice from community pharmacies, both within and beyond the funded service, as revealed
by recent sector polling.
To accurately assess this trend and advocate for sustainable funding, CPE is initiating an audit to gather data crucial for showcasing the extent of unfunded
care provided by community pharmacies.
Scheduled to commence this week, the Pharmacy Advice Audit will entail pharmacy teams documenting informal healthcare advice dispensed over a single day.
As the general election campaign continues, Labour is set to introduce a series of policies aimed at supporting small businesses.
On Saturday, Sir Keir Starmer, alongside shadow chancellor Rachel Reeves and other shadow cabinet ministers, is expected to unveil the party's plans for the sector.
Key proposals include an overhaul of the business rates system to enable high street shops to compete with online giants and ensure access to high street
banking services by accelerating the establishment of banking hubs.
Labour will also commit to addressing the issue of late payment of invoices by requiring large businesses to disclose their payment practices and "revitalise" high
streets by tackling antisocial behaviour.
Sir Keir described small businesses as "the beating heart of driving growth and creating jobs for local people."
A recent analysis conducted by the Company Chemists' Association (CCA) has revealed stark disparities in patient engagement with the Pharmacy First
service across the country, likening the pattern to a 'patchwork quilt'.
It indicated that patients in the highest-performing Integrated Care System (ICS) received seven times more Pharmacy First consultations than those in the
lowest-performing regions.
As of April 21, more than 3,000 CCA member pharmacies had delivered 126,484 Pharmacy First consultations since the programme's launch.
However, the analysis found significant regional variations, with nearly 13,000 consultations completed in the North East and North Cumbria ICS, while only
948 were completed in Gloucestershire ICS.
The CCA calculated that if every ICS had as many consultations as the highest-performing ICS, there would have been an additional 600,000 Pharmacy First
consultations nationwide.
Darren Jones MP, the Shadow Chief Secretary to the Treasury, visited Sigma Pharmaceuticals plc's new Watford facility on Thursday (6 June) as part of the
imminent Labour Party campaign trail.
Jones was joined by Labour's prospective parliamentary candidate for Watford, Matt Turmaine, and a team of campaign workers.
During their visit, the Labour delegation met with the directors and founding member of Sigma, Dr Bharat Shah CBE, and discussed the importance of investment
and support for growing businesses and the pharmaceutical sector both in the region and across the country.
Sigma Pharmaceuticals, which is believed to be Watford's largest employer, noted that the pharmaceutical sector contributes a significant value to the East of
England, accounting for 12.3 per cent of the region's manufacturing gross value added (GVA).
In response to significant ongoing disruptions in the supply of certain Quetiapine tablet strengths, the Department of Health and Social Care (DHSC) on Tuesday
issued nine new Serious Shortage Protocols (SSPs), with immediate effect.
These measures aim to ensure the continued availability of quetiapine, an essential medication for managing schizophrenia and bipolar disorder.
Under the new SSPs, community pharmacists are allowed to consider different options to manage the shortage of the three strengths of quetiapine tablets affected
by ongoing supply disruptions: quetiapine 300mg tablets, quetiapine 200mg tablets, and quetiapine 150mg tablets.
Depending on the prescribed quantity of the affected quetiapine tablet, pharmacists can either supply a reduced quantity of the same quetiapine tablet or
substitute with an alternative strength or provide a reduced quantity of a specific alternative product.